Clinical Report: Environmental Impact of Standard IBD Surgical Treatments
Overview
This study prospectively assessed the carbon footprint of three common laparoscopic surgeries for inflammatory bowel disease (IBD): ileocecal resection (ICR) for Crohn’s disease, subtotal colectomy (STC) for ulcerative colitis, and the LIFT procedure for Crohn’s perianal fistula. Using life cycle assessment methodology, the study identified key contributors to greenhouse gas emissions in these surgeries, providing a foundation for developing targeted carbon-reduction strategies.
Background
Climate change poses a significant health threat globally, with healthcare systems contributing substantially to greenhouse gas (GHG) emissions. Surgical procedures are notable sources of both direct and indirect GHG emissions within hospitals. In chronic diseases like IBD, cumulative environmental impacts of treatments are increasingly relevant in clinical decision-making alongside quality of life and cost-effectiveness. However, data on the carbon footprint of IBD-related surgeries have been lacking, prompting this prospective multicenter study to quantify emissions associated with laparoscopic ICR, STC, and LIFT procedures.
Data Highlights
Surgery Type
Number of Procedures
Setting
Study Period
Laparoscopic Ileocecal Resection (ICR)
8
Two Dutch nonacademic teaching hospitals
March 2023 - May 2024
Laparoscopic Subtotal Colectomy (STC)
8
Two Dutch nonacademic teaching hospitals
March 2023 - May 2024
Ligation of Intersphincteric Fistula Tract (LIFT)
8
Two Dutch nonacademic teaching hospitals
March 2023 - May 2024
Key Findings
The study included 24 laparoscopic surgeries: 8 ICR, 8 STC, and 8 LIFT procedures, all performed in two Dutch teaching hospitals.
Life cycle assessment (LCA) methodology was used to quantify the carbon footprint of each surgical procedure, incorporating all products and processes involved.
Surgical theaters contribute significantly to both direct and indirect greenhouse gas emissions through energy use, supplies, and waste production.
The study identified surgery-specific components responsible for the largest carbon emissions, enabling targeted reduction strategies.
This is the first prospective study to quantify GHG emissions specifically for laparoscopic ICR, STC, and LIFT procedures in IBD patients.
Clinical Implications
Clinicians should consider the environmental impact of surgical treatment options for IBD alongside clinical efficacy and cost-effectiveness. Understanding the carbon footprint of different procedures allows for informed decision-making and supports the development of sustainable surgical practices. Incorporating environmental outcomes into treatment planning may reduce the healthcare sector’s contribution to climate change without compromising patient care.
Conclusion
This study provides crucial data on the carbon footprint of key laparoscopic surgeries for IBD, highlighting opportunities for sustainability improvements. Integrating environmental impact assessments into clinical pathways can promote greener healthcare delivery in chronic disease management.
References
World Health Organization 2021 -- Climate Change and Health
Healthcare Emissions Studies 2020-2023 -- Global and National Contributions
LIR!C Trial 2018-2019 -- Surgical vs. Medical Treatment in Crohn’s Disease
Life Cycle Assessment Methodology 2023 -- EcoInvent Database and SimaPro Software
by L. Munster, B. van der Zwet, J. de Groof, M. Mundt, O. van Ruler, G. D’Haens, W. Bemelman, C. Buskens, M. Duijvestein, T. Stobernack, J. van der Bilt
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production